These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Determination of excipient based solubility increases using the CheqSol method. Etherson K; Halbert G; Elliott M Int J Pharm; 2014 Apr; 465(1-2):202-9. PubMed ID: 24513529 [TBL] [Abstract][Full Text] [Related]
8. Equilibrium versus kinetic measurements of aqueous solubility, and the ability of compounds to supersaturate in solution--a validation study. Box KJ; Völgyi G; Baka E; Stuart M; Takács-Novák K; Comer JE J Pharm Sci; 2006 Jun; 95(6):1298-307. PubMed ID: 16552741 [TBL] [Abstract][Full Text] [Related]
9. Solubility-pH profiles of some acidic, basic and amphoteric drugs. Shoghi E; Fuguet E; Bosch E; Ràfols C Eur J Pharm Sci; 2013 Jan; 48(1-2):291-300. PubMed ID: 23178441 [TBL] [Abstract][Full Text] [Related]
10. Potentiometric CheqSol and standardized shake-flask solubility methods are complimentary tools in physicochemical profiling. Lucero-Borja D; Subirats X; Barbas R; Prohens R; Avdeef A; Ràfols C Eur J Pharm Sci; 2020 May; 148():105305. PubMed ID: 32184154 [TBL] [Abstract][Full Text] [Related]
11. Absorption-excipient-pH classification gradient maps: sparingly soluble drugs and the pH partition hypothesis. Avdeef A; Kansy M; Bendels S; Tsinman K Eur J Pharm Sci; 2008 Jan; 33(1):29-41. PubMed ID: 17983735 [TBL] [Abstract][Full Text] [Related]
12. Modelling, solubility and pK(a) of five sparingly soluble drugs. Domańska U; Pobudkowska A; Pelczarska A; Zukowski L Int J Pharm; 2011 Jan; 403(1-2):115-22. PubMed ID: 21034801 [TBL] [Abstract][Full Text] [Related]
13. Use of a physiologic bicarbonate buffer system for dissolution characterization of ionizable drugs. McNamara DP; Whitney KM; Goss SL Pharm Res; 2003 Oct; 20(10):1641-6. PubMed ID: 14620520 [TBL] [Abstract][Full Text] [Related]
14. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Kawabata Y; Wada K; Nakatani M; Yamada S; Onoue S Int J Pharm; 2011 Nov; 420(1):1-10. PubMed ID: 21884771 [TBL] [Abstract][Full Text] [Related]
15. Salt disproportionation: A material science perspective. Thakral NK; Kelly RC Int J Pharm; 2017 Mar; 520(1-2):228-240. PubMed ID: 28163222 [TBL] [Abstract][Full Text] [Related]
16. Dissolution-modulating mechanism of pH modifiers in solid dispersion containing weakly acidic or basic drugs with poor water solubility. Tran PH; Tran TT; Lee KH; Kim DJ; Lee BJ Expert Opin Drug Deliv; 2010 May; 7(5):647-61. PubMed ID: 20205605 [TBL] [Abstract][Full Text] [Related]
17. A potentiometric titration method for the crystallization of drug-like organic molecules. Du-Cuny L; Huwyler J; Fischer H; Kansy M Int J Pharm; 2007 Sep; 342(1-2):161-7. PubMed ID: 17587517 [TBL] [Abstract][Full Text] [Related]
18. Oral lipid-based formulations. Hauss DJ Adv Drug Deliv Rev; 2007 Jul; 59(7):667-76. PubMed ID: 17618704 [TBL] [Abstract][Full Text] [Related]
19. Critical comparison of shake-flask, potentiometric and chromatographic methods for lipophilicity evaluation (log P Port A; Bordas M; Enrech R; Pascual R; Rosés M; Ràfols C; Subirats X; Bosch E Eur J Pharm Sci; 2018 Sep; 122():331-340. PubMed ID: 30006180 [TBL] [Abstract][Full Text] [Related]